Imstem Biotechnology: ImStem therapy reverses multiple sclerosis symptoms in mice
Researchers from ImStem Biotechnology, University of Connecticut Health Center and Advanced Cell Technology have successfully treated mice with multiple sclerosis using human embryonic stem cells derived from mesenchymal stem cells, known as hES-MSCs.
Read full article »
Imstem is a Connecticut-based biotechnology company that develops and commercializes stem cell based regenerative cellular therapies for the treatment of serious diseases.
Read more